Back
MicroSectors Gold Miners 3X Leveraged ETN Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Buy
90
GDXU
MicroSectors Gold Miners 3X Leveraged ETN
Last Price:
$289.00
Seasonality Move:
18.71%
Buy
64
LYEL
Lyell Immunopharma, Inc.
Last Price:
$37.17
Seasonality Move:
-16.78%
Buy
90
MicroSectors Gold Miners 3X Leveraged ETN (GDXU)
is a Buy
Is MicroSectors Gold Miners 3X Leveraged ETN a Buy, Sell or Hold?
-
The current MicroSectors Gold Miners 3X Leveraged ETN [GDXU] share price is $288.40. The Score for GDXU is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
-
GDXU is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
64
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $37.37. The Score for LYEL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GDXU Stock Price Chart
What is MicroSectors Gold Miners 3X Leveraged ETN's stock price today?
-
The MicroSectors Gold Miners 3X Leveraged ETN share price today is $288.40Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GDXU is experiencing slight buying pressure.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $37.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight selling pressure.
GDXU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 21.43 | Buy |
| Relative Strength Index (14 RSI): | 73.11 | Buy |
| Chaikin Money Flow: | 96521 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (178.21 - 245.31) | Buy |
| Bollinger Bands (100): | (115.34 - 217.66) | Buy |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.08 | Buy |
| Relative Strength Index (14 RSI): | 79.16 | Buy |
| Chaikin Money Flow: | -97373 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.11 - 32.35) | Buy |
| Bollinger Bands (100): | (10.77 - 23.75) | Buy |
GDXU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 249.55 | Buy |
| 20-day SMA: | 223.82 | Buy |
| 50-day SMA: | 194.43 | Buy |
| 200-day SMA: | 116.45 | Buy |
| 8-day EMA: | 250.55 | Buy |
| 20-day EMA: | 227.1 | Buy |
| 50-day EMA: | 198.68 | Buy |
| 200-day EMA: | 112.74 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.51 | Buy |
| 20-day SMA: | 28.33 | Buy |
| 50-day SMA: | 21.67 | Buy |
| 200-day SMA: | 13.52 | Buy |
| 8-day EMA: | 33.02 | Buy |
| 20-day EMA: | 28.99 | Buy |
| 50-day EMA: | 23.45 | Buy |
| 200-day EMA: | 17.42 | Buy |
MicroSectors Gold Miners 3X Leveraged ETN Earnings Growth & GDXU Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
MicroSectors Gold Miners 3X Leveraged ETN Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||